Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Enterprise Value (2018 - 2025)

Dna X filings provide 8 years of Enterprise Value readings, the most recent being -$1.3 million for Q4 2025.

  • On a quarterly basis, Enterprise Value rose 83.79% to -$1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 million, a 83.79% increase, with the full-year FY2025 number at -$1.3 million, up 83.79% from a year prior.
  • Enterprise Value hit -$1.3 million in Q4 2025 for Dna X, up from -$4.3 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$101000.0 in Q1 2024 to a low of -$13.9 million in Q1 2021.
  • Median Enterprise Value over the past 5 years was -$5.2 million (2025), compared with a mean of -$5.8 million.
  • Biggest five-year swings in Enterprise Value: soared 98.95% in 2024 and later plummeted 5235.29% in 2025.
  • Dna X's Enterprise Value stood at -$12.3 million in 2021, then decreased by 7.65% to -$13.2 million in 2022, then skyrocketed by 97.74% to -$299000.0 in 2023, then plummeted by 2588.96% to -$8.0 million in 2024, then soared by 83.79% to -$1.3 million in 2025.
  • The last three reported values for Enterprise Value were -$1.3 million (Q4 2025), -$4.3 million (Q3 2025), and -$5.4 million (Q2 2025) per Business Quant data.